Summer 2026

Process Innovation – Software Engineering Intern

Updated on 7/22/2026

Altasciences

Altasciences

1,001-5,000 employees

Integrated CRO for early-phase drug development

No salary listed

Overland Park, KS, USA

Remote

Category
AI & Machine Learning (1)

Get referred to Altasciences

Find people who can refer or advise you

Requirements
  • High School Seniors through rising college Juniors with a serious interest in computer science or software engineering.
  • We are not looking for a long resume – we are looking for curiosity, the habit of building things, and comfort sitting with ambiguity.
  • If you've taught yourself something outside of class, broken and fixed your own code, or have opinions about how software should be built, we want to hear from you.
Responsibilities
  • Building and breaking small prototypes – trying things, throwing them out, trying again
  • Working with real document content (templates, historical reports, source data) to figure out what's possible
  • Wiring together LLM APIs, OCR tooling, and whatever else the problem calls for
  • Pair-programming and reviewing each other's work; you won't be siloed
  • Sitting in on user interviews with report authors so you understand who you're building for
  • Presenting what you've built (and what hasn't worked) to stakeholders, including senior leadership

Altasciences provides an integrated CRO that handles the full early‑phase drug development path, from preclinical testing through clinical proof of concept and into manufacturing. Its approach combines discovery support, safety testing, clinical trial execution, and in‑house manufacturing to run programs under one roof. This contrasts with competitors that require pharma and biotech clients to source services from multiple vendors, adding complexity and risk; Altasciences streamlines the process by coordinating all steps. The company aims to help innovator drug programs move quickly and efficiently, delivering integrated data to de‑risk decisions and speed progression to later stages.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$6.7M

Headquarters

Laval, Canada

Founded

1976

Get referred to Altasciences

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Strategic Certara partnership embeds biosimulation to enable earlier proof of mechanism and refined dosing.
  • RegulatoryFlow AI from Evidence Matters automates one-third of nonclinical reports to expedite timelines.
  • 258 active hiring postings in 2025 signal capacity expansion supporting integrated model and growth.

What critics are saying

  • Certara integration enables sponsors to make go/no-go decisions earlier, reducing later-phase trial volume and revenue.
  • AI tools like RegulatoryFlow and Instill erode preclinical consulting margins and program management revenue by 20–30%.
  • Smaller CROs expanding early-phase with lower pricing may force loss of 15–25% of Phase I contracts in 6–12 months.

What makes Altasciences unique

  • Fully integrated CRO/CDMO spans preclinical to clinical proof of concept under one supplier.
  • Proprietary Acceleration Platform reduces timelines by 25–40% via parallel execution and single-point contact.
  • Eight global facilities and 1,800+ employees deliver 98% on-time delivery for early-phase trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Employee Assistance & Telehealth Programs

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

4%

1 year growth

4%

2 year growth

8%
GlobeNewswire
Mar 16th, 2026
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note

ISELIN, N.J., March 16, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard...

Business Wire
Aug 20th, 2025
Altasciences Receives EcoVadis Gold Medal for Environmental, Social, and Governance (ESG) Efforts

EcoVadis, the world's most trusted provider of business sustainability ratings, has collaborated closely with Altasciences to enhance its environmental, social, and governance (ESG) initiatives, underscoring the company's commitment to a sustainable future and a reduced environmental footprint.

Yahoo Finance
Jul 31st, 2025
Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

This partnership combines Altasciences' comprehensive early-phase drug development capabilities with VoxCell's cutting-edge 3D tissue technology to offer a more predictive and human-relevant preclinical testing environment.

Postmedia Network
Mar 28th, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category

For 14 years, Outsourced Pharma's CDMO Leadership Awards have recognized the top-performing contract development and manufacturing organizations based on comprehensive industry research, and feedback from sponsors.

BioSpace
May 29th, 2024
Altasciences Receives 2024 CRO Leadership Award for Capabilities

Altasciences receives 2024 CRO Leadership Award for Capabilities.